Kuwait Cancer Control Center approves a diagnostic service the first of its kind in the Middle East

  • 11/12/2021

The Kuwait Cancer Control Center of the Ministry of Health has recently approved a diagnostic service, "the first of its kind in the Middle East", concerned with diagnosing breast cancer and its spread and assessing the response to hormonal therapy.

Director of the (Center) Dr. Hadeel Al-Mutawa told Kuwait News Agency (KUNA) today, Friday, that the new service that has been approved in the Nuclear Medicine Unit is based on the use of a substance known as (F18-FES), a positron-radiation material concerned with diagnosing hormone receptors for breast cancer patients.

Al-Mutawa explained that breast cancer ranks first as the most common type of disease locally, regionally and globally, noting that early detection increases the cure rate, as well as the options and effectiveness of the treatment used.

For her part, Head of the Medical Imaging Department at the Center, Dr. Mashael Bandar, said in a similar statement that "the production of (F18-FES) is the third of the center's cyclotron accelerator (a device for accelerating charged particles)", stressing the keenness to produce new materials to keep pace with The latest global developments and the upgrading of health and diagnostic services in the State of Kuwait.

In turn, the head of the nuclear medicine department at the center, Dr. Farida Al-Kandari, stressed to (KUNA) the importance of the new diagnostic service, as it includes diagnosing the spread of the disease, evaluating the response to hormonal therapy and the possibility of recurring infection.




Related News